| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SPERT | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | MMRN2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | TOX2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | KLRB1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CHAC2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | DHRS4L2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | LAMTOR2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | HSPB2-C11orf52 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GBE1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | EMD | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
